The purpose of this report is to provide an evidence-based, best practice summary to optimize the quality, safety and efficacy, and availability of renal rehabilitation service, and to provide care for maximum patient prognosis, quality of life, and satisfaction.
Featured article: Clinical practice guideline for renal rehabilitation: systematic reviews and recommendations of exercise therapies in patients with kidney diseases
Featured article: The features of bone articular lesions in dialysis-related amyloidosis (DRA) and criteria for the clinical diagnosis of DRA
Dialysis-related amyloidosis (DRA) is a type of systemic amyloidosis. Compared to the clinical features of other types of systemic amyloidosis, such as immunoglobulin light chain amyloidosis (AL) and inflammatory amyloidosis (AA) types, the clinical features of DRA are distinct in terms of preferential amyloid deposition at multiple bone articular lesions.
Featured article: Assessment of the effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in peritoneal dialysis patients: a systematic review and meta-analysis on clinical trials
Residual renal function (RRF) is recognized as a significant factor in improving the prognosis of patients undergoing peritoneal dialysis (PD). Preserving RRF contributes to achieving adequate dialysis targets and improving fluid status.
Articles
-
-
Comparison of difficulty with activities of daily living in elderly adults undergoing hemodialysis and community-dwelling individuals: a cross-sectional study
-
A high likelihood of increase in end-stage renal disease among the Japanese HIV-infected population
-
Plasma exchange for thrombotic microangiopathy secondary to dermatomyositis associated with acute kidney injury and complement activation: a case report with literature review
-
Sex differences in uric acid levels in kidney transplant recipients and their donors: a preliminary retrospective cross-sectional study
2019
Thematic series
Official Guideline and Registry Data of Renal Replacement Therapy
Upcoming conferences
The 65th Annual Meeting of the Japanese Society for Dialysis Therapy
12−14 June 2020, Osaka International Convention Center, RIHGA Royal Hotel Osaka
The 66th Annual Meeting of the Japanese Society for Dialysis Therapy
4-6 June 2021, Pacifico Yokohama
The 25th Annual Meeting of the Japanese Society for Peritoneal Dialysis
23-24 November - 30 November 2019, Hiroshima International Conference Center
The 26th Annual Meeting of the Japanese Society for Peritoneal Dialysis
19-20 September 2020, Keio Plaza Hotel Tokyo
The 30th Annual Meeting of the Japan Society for Blood Purification Critical Care
26-27 October 2019, Hamamatsu ACT
The 31st Annual Meeting of the Japan Society for Blood Purification Critical Care
17-18 October 2020, Kofu Memorial Day's Hotel
The 32nd Annual Meeting of the Japan Society for Blood Purification Critical Care
2-3 October 2021, Rafre Saitama
The 10th Annual Meeting of the Japanese Society of Renal Rehabilitation
22-23 February 2020, Bellesalle Shinjuku Grand Conferance Center
The 11th Annual Meeting of the Japanese Society of Renal Rehabilitation
20-21 March 2021, Sendai International Center
The 13th Annual Meeting of the Japanese Society of Nephrology and Pharmacotherapy
15-17 November 2019, Kumamoto-Jo Hall
The 14th Annual Meeting of the Japanese Society of Nephrology and Pharmacotherapy
28-29 November 2020, Awagin Hall Tokushima
Submit your manuscript
Please use the online submission system to submit your manuscript. For all enquiries about the journal, please access the site and click Contact Us.
Aims and scope
Renal Replacement Therapy is a peer-reviewed journal facilitating worldwide discussion of research and issues related to the study of renal replacement therapy.
RRT considers articles on all aspects of hemodialysis, peritoneal dialysis, blood purification, renal transplantation and regenerative medicine. In addition, the journal publishes content in wider fields such as chronic kidney disease (CKD), acute kidney injury (AKI), critical care medicine and intensive care, bone and mineral metabolism, anemia and iron metabolism, infection, cardiac disease, cerebral disease, diabetes mellitus, hypertension, nutrition, and related social issues. Contributions are encouraged from a global perspective across many disciplines.
Overcoming Language Barriers
If your manuscript could benefit from improvements to the English language, you should have your manuscript reviewed by someone who is fluent in English. For a collection of free resources to help with writing in English please visit here. If you would like professional help, we recommend our affiliates Nature Research Editing Service and American Journal Experts for help with English usage. BMC authors receive 10% off their first submission to either service. Please note that use of an editing service is neither a requirement nor a guarantee of publication.
Society affiliations
Renal Replacement Therapy is the official publication of the following societies:
- Japanese Society for Dialysis Therapy (JSDT)
- Japanese Society for Clinical Renal Transplantation (JSCRT)
- Japanese Society for Peritoneal Dialysis (JSPD)
- Japan Society for Blood Purification in Critical Care (JSBPCC)
- Japanese Society of Renal Rehabilitation (JSRR)
- Japanese Society of Nephrology and Pharmacotherapy (JSNP)
About the Editor
Prof Takashi Shigematsu, Editor-in-Chief
Prof Shigematsu is currently Professor and Director of the Division of Nephrology, Department of Internal Medicine at the Wakayama Medical University School of Medicine, Japan. He is also Director of Blood purification Medicine, and Clinical Engineering at Wakayama Medical University Hospital, as well as a member of the International Society of Nephrology and the American Society of Nephrology.
His research interests focus on bone and mineral metabolism within chronic kidney disease (CKD). In addition, he has been investigating and working in fields of hemodialysis, peritoneal dialysis, blood purification medicine in acute kidney injury, kidney transplantation.
Advertisement
Annual Journal Metrics
-
Speed
45 days to first decision for reviewed manuscripts only
45 days to first decision for all manuscripts
128 days from submission to acceptance
27 days from acceptance to publication
Usage
146,202 Downloads
23 Altmetric mentions
Advertisement
